U-PTIX

Q:PTIX - PROTAGENIC THERAPEUTICS INC - https://protagenic.com/

01:54:04 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
PTIX - Q	not subscribed					0.59	+0.05	9.3	6.4	3	34	0.63 0.65 0.54	14.28 1.12	15:58:34	Dec 09	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market: OTC Markets -- Tier: OTC Pink Limited -- Status: Active

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Portfolio

Recent Trades - Last 10 of 34

More trades...

Time ET	Ex	Price	Change	Volume
15:58:34	Q	0.59	0.05	115
15:53:11	Q	0.65	0.11	200
15:39:11	Q	0.64	0.10	185
15:10:30	Q	0.59	0.05	1
14:38:47	Q	0.64	0.10	490
14:10:12	Q	0.5655	0.0255	1
12:55:15	Q	0.52	-0.02	18
12:47:51	Q	0.525	-0.015	50
11:53:48	Q	0.54		1,113
11:53:36	Q	0.54		1,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2025-12-09 08:46	U:PTIX	News Release200	Results from Phase 1 Multiple-Dose Study of PT00114
2025-11-13 08:22	U:PTIX	News Release200	Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
2025-08-22 17:26	U:PTIX	News Release200	Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
2025-08-21 08:12	U:PTIX	News Release200	Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
2025-07-30 08:30	U:PTIX	News Release200	Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
2025-05-22 04:22	U:PTIX	News Release200	Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
2025-05-21 09:19	U:PTIX	News Release200	Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
2025-05-19 07:45	U:PTIX	News Release200	Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders
2025-04-29 16:03	U:PTIX	News Release200	Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split

Date ET

Symbol

Type

Headline

2025-12-09 08:46

U:PTIX

News Release

Results from Phase 1 Multiple-Dose Study of PT00114

2025-11-13 08:22

U:PTIX

News Release

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study